THE LATEST NEWS ON MERGERS & ACQUISITIONS, CAPITAL MARKETS AND TECH TRENDS

PHOTO: GOLDMAN SACHS

Hedge funds on stock buying spree, as markets cap historic May rally

The S&P 500 advanced over 6% last month, its biggest monthly rise since November 2023 and its best gains since 1990, while the Nasdaq rallied about 9.6%, also its biggest since November and its best since 1997, Goldman Sachs said. Read here

Sanofi buys US biopharma Blueprint for up to $9.5B

The pharmaceutical giant has agreed to acquire the Massachusetts-based clinical-stage biopharmaceutical group to boost its position in rare immunology diseases, in the biggest deal struck by a European healthcare company. Read here

PHOTO: HUGH VENABLES

Sanofi,_Rookwood_Way_-_geograph.org.uk_-_4693137_Hugh Venables

Digital banking startup Chime targets $9.5B in IPO

The California-based fintech company is targeting a valuation of up to $9.47 billion in its long-awaited New York initial public offering, in what would be the biggest US listing since the White House's sweeping tariffs. Read here

PHOTO: CHIME

James Hardie secures $3.5B credit for AZEK deal

The ASX-listed fiber cement specialist has secured new senior credit facilities with broad support, including 30 participating banks, in its acquisition of the Chicago-based building materials manufacturer. Read here

PHOTO: AZEK

NEWS WORTH NOTING

AVPro buys automation solutions firm RTI Control

The South Dakota-based parent company of AVPro Edge, AudioControl Pro, Bullet Train, ThenAudio, and Murideo has entered into an agreement to acquire the Minnesota-based intelligent home specialist. Read here

PHOTO: CYNDX

DEALS ROUNDUP

INTERNATIONAL MARKETS

Poland’s PZU, Bank Pekao planning $27B combination

The Polish state-controlled insurer plans to merge with the country’s largest lender in a potential deal that could result in the biggest financial M&A transaction in Europe. Read here

BioNTech, Bristol Myers in $11B cancer drug tie-up

The German biotech company and the US biopharma are co-developing an experimental bispecific antibody BNT327 intended for use in various solid tumor types. Read here

BASF unveils $6.9B coatings unit sale, attracts PE majors

The German chemical giant has kicked off the sale process for its coatings business, drawing attention from a growing roster of global buyout firms including Carlyle Group. Read here

HSBC commits $4B in push

to fund $50B credit platform

London-based HSBC Asset Management is making a major commitment to private credit, with Europe’s largest bank set to invest its own capital into an alternative credit funds. Read here

Know someone who would benefit

from the Cyndx platform?

Join our Referral Program

and be compensated!

SUBMIT A NAME NOW

Join Our LinkedIn Community

Questions? Please email us at marketing@cyndx.com.

Did a friend forward you this email? Subscribe here.